UPDATE 1 — Liquidia surges as United Therapeutics settlement removes key litigation risk
(Updates shares in paragraph 1, rewrites headline) Oct 14 (Reuters) — Liquidia shares jumped nearly 37% in premarket trading on Wednesday after the drugmaker settled a years-long legal dispute with United Therapeutics over its lung disease drug. The settlement, announced late on Tuesday, ends six lawsuits over patents,